Non-steroidal aromatase inhibitors based on a biphenyl scaffold: Synthesis, in vitro SAR, and molecular modelling

被引:32
作者
Jackson, Toby [1 ,2 ]
Woo, L. W. Lawrence [1 ,2 ]
Trusselle, Melanie N. [1 ,2 ]
Purohit, Atul [3 ]
Reed, Michael J. [3 ]
Potter, Barry V. L. [1 ,2 ]
机构
[1] Univ Bath, Sterix Ltd, Bath BA2 7AY, Avon, England
[2] Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[3] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Fac Med, Sterix Ltd, London W2 1NY, England
关键词
aromatase inhibitors; biphenyls; breast cancer; endocrine therapy; triazoles;
D O I
10.1002/cmdc.200700266
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and in vitro biological evaluation (JEG-3 cells) of a series of novel and potent aromatose inhibitors, prepared by microwave-enhanced Suzuki cross-coupling methodology, are reported. These compounds possess a biphenyl template incorporated with the haem-ligating triazolylmethyl moiety, either on its own or in combination with other substituent(s) at various positions on the phenyl rings. The most potent aromatase inhibitor reported herein has an IC50 value of 0.12 nM, although seven of its congeners are also highly potent (IC50 <= 0.5 nM). They all bear the (5-triazolylmethyl-2-cyano)biphenyl structural motif Docking of representative compounds into a homology model of human aromatase assists in the rationalisation of the SAR derived from the in vitro biological results and supports a crucial role for a cyano group on the "A" phenyl ring, which is accessible to hydrogen bond interactions with Ser478. Further development of these compounds as potential therapeutic agents for the treatment of hormone-dependent breast cancer is warranted given the high level of potency observed for this class of aromatase inhibitor in vitro.
引用
收藏
页码:603 / 618
页数:16
相关论文
共 31 条
[1]   Palladium catalysts for the Suzuki cross-coupling reaction: An overview of recent advances [J].
Bellina, F ;
Carpita, A ;
Rossi, R .
SYNTHESIS-STUTTGART, 2004, (15) :2419-2440
[2]   Aromatase inhibitors in the treatment of breast cancer [J].
Brueggemeier, RW ;
Hackett, JC ;
Diaz-Cruz, ES .
ENDOCRINE REVIEWS, 2005, 26 (03) :331-345
[3]   Looking for selectivity among cytochrome P450s inhibitors [J].
Cavalli, A ;
Recanatini, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :251-254
[4]  
DeLano W. L., 2002, PYMOL
[5]   Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes [J].
Favia, AD ;
Cavalli, A ;
Masetti, M ;
Carotti, A ;
Recanatini, M .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) :1074-1087
[6]   AROMATASE INHIBITORS - SYNTHESIS, BIOLOGICAL-ACTIVITY, AND BINDING MODE OF AZOLE-TYPE COMPOUNDS [J].
FURET, P ;
BATZL, C ;
BHATNAGAR, A ;
FRANCOTTE, E ;
RIHS, G ;
LANG, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1393-1400
[7]   Imidazolylmethylbenzophenones as highly potent aromatase Inhibitors [J].
Gobbi, Silvia ;
Cavalli, Andrea ;
Negri, Matthias ;
Schewe, Katarzyna E. ;
Belluti, Federica ;
Piazzi, Lorna ;
Hartmann, Rolf W. ;
Recanatini, Maurizio ;
Bisi, Alessandra .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (15) :3420-3422
[8]   Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme [J].
Gobbi, Silvia ;
Cavalli, Andrea ;
Rampa, Angela ;
Belluti, Federica ;
Piazzi, Lorna ;
Paluszcak, Anja ;
Hartmann, Rolf W. ;
Recanatini, Maurizio ;
Bisi, Alessandra .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) :4777-4780
[9]  
Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO
[10]  
2-T